Loading provider…
Loading provider…
Gastroenterology Physician in Houston, TX
NPI: 1306287370Primary Practice Location
Vikram S. Jayanty,M.D.,PA
10837 Katy Fwy, Houston, TX
Primary Employer
Vikram S. Jayanty,M.D.,PA
houstongidocs.com
HQ Phone
Get M.D. Julien's Phone Numberphone_androidMobile
Get M.D. Julien's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
WI State Medical License
TX State Medical License
TX State Medical License
2023 - 2026
WY State Medical License
2019 - 2025
WI State Medical License
2016 - 2019
MA State Medical License
2013 - 2016

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Gastroenterology
Aurora Health Care
Fellowship • Gastroenterology
2016 - 2019
UMass Chan Medical School
umassmed.edu
Residency • Internal Medicine
2013 - 2016
St Joseph's University Medical School
Medical School
Until 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 215 | 270 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 163 | 173 |
| 3 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 149 | 149 |
| 4 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | 87 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 87 | 87 |
Smoking Cessation in a Chronic Pancreatitis Population.
Authors: Samuel Han, Joan Kheder
Publication Date: 2016-04-22
Clostridium difficile in inflammatory bowel disease: a retrospective study
Authors: Gillespie, William, Marya, Neil, Fahed, Julien, Leslie, Gregory, Patel, Krunal, Cave, David R
Journal: Gastroenterol Res Pract
Publication Date: 2017-10-04
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab